Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.
Dampier CH, Shah N, Galbraith K, Ebrahimi A, Neto OLA, Abdullaev Z, Alexandrescu S, Andreiuolo F, Armstrong T, Baker T, Cathcart S, Chung HJ, Cimino PJ, Conway KS, Cotter J, Costa FD, Dazelle K, Etminam N, Ferman SE, Fernandes I, Ferrone CK, Gilani A, Gilbert M, Gregory J, Ketchum C, Lee HS, Lee I, Lopes MBS, Mao Q, Marshall MS, McCord M, Neill SG, Nirschl JJ, Ozer BH, Paulus W, Penas-Prado M, Prinz M, Pytel P, Quezado M, Raffeld M, Rajan S, Ratliff M, Reifenberger G, Robinson L, Schittenhelm J, Schrimpf D, Singh O, Thomas C, Thomas D, Thomas-Ogunniyi J, Toland A, Turakulov R, Vaubel R, Wadhwani N, Wu J, Giannini C, Snuderl M, Brandner S, von Deimling A, Aldape K.
Dampier CH, et al. Among authors: ferman se.
Neurooncol Adv. 2025 Jul 19;7(1):vdaf089. doi: 10.1093/noajnl/vdaf089. eCollection 2025 Jan-Dec.
Neurooncol Adv. 2025.
PMID: 40735274
Free PMC article.